These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12716823)

  • 1. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.
    Ceriello A
    Diabetes Care; 2003 May; 26(5):1589-96. PubMed ID: 12716823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets of diabetic vascular complications and potential new drugs.
    Da Ros R; Assaloni R; Ceriello A
    Curr Drug Targets; 2005 Jun; 6(4):503-9. PubMed ID: 16026269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
    Kiss L; Szabó C
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant therapy in diabetic complications: what is new?
    Da Ros R; Assaloni R; Ceriello A
    Curr Vasc Pharmacol; 2004 Oct; 2(4):335-41. PubMed ID: 15320813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gliclazide beyond metabolic control.
    Ceriello A
    Metabolism; 2006 May; 55(5 Suppl 1):S10-5. PubMed ID: 16631804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
    Pacher P; Szabó C
    Antioxid Redox Signal; 2005; 7(11-12):1568-80. PubMed ID: 16356120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance.
    Da Ros R; Assaloni R; Ceriello A
    Diabet Med; 2004 Nov; 21(11):1249-52. PubMed ID: 15498094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and diabetes-associated complications.
    Ceriello A
    Endocr Pract; 2006; 12 Suppl 1():60-2. PubMed ID: 16627383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.
    Soriano FG; Virág L; Szabó C
    J Mol Med (Berl); 2001 Aug; 79(8):437-48. PubMed ID: 11511974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel antioxidant therapeutic strategies for cardiovascular dysfunction associated with ageing].
    Radovits T
    Orv Hetil; 2008 Dec; 149(50):2377-85. PubMed ID: 19073445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postprandial hyperglycemia as a risk factor in the development of endothelial dysfunction--how to prevent?].
    Ljubić S; Boras J; Vidjak V
    Lijec Vjesn; 2008; 130(1-2):21-5. PubMed ID: 18589639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.
    Szabo C
    Br J Pharmacol; 2009 Mar; 156(5):713-27. PubMed ID: 19210748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
    Pacher P; Obrosova IG; Mabley JG; Szabó C
    Curr Med Chem; 2005; 12(3):267-75. PubMed ID: 15723618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.
    Ceriello A
    Curr Opin Lipidol; 2006 Oct; 17(5):510-8. PubMed ID: 16960499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP; Palmeira CM
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.
    Du X; Matsumura T; Edelstein D; Rossetti L; Zsengellér Z; Szabó C; Brownlee M
    J Clin Invest; 2003 Oct; 112(7):1049-57. PubMed ID: 14523042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.
    Johansen JS; Harris AK; Rychly DJ; Ergul A
    Cardiovasc Diabetol; 2005 Apr; 4():5. PubMed ID: 15862133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.
    Mabley JG; Soriano FG
    Curr Vasc Pharmacol; 2005 Jul; 3(3):247-52. PubMed ID: 16026321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.